Mobile Smoking Treatment for Hispanic Individuals Who Smoke

ConditionSmoking Cessation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorUniversity of Houston

About this trial

The specific aims of the project are to develop and test a mobile application for smoking cessation for Hispanic individuals who smoke called Impacto.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1) being Hispanic, 2) at least 18 years of age, 2) currently smoking (i.e., at least 5 cigarettes/day) biochemically verified by a CO > 7, 3), meeting criteria for high AS (cut-off score of 5 on the Short Scale Anxiety Sensitivity Index), 4) motivation to quit > 5 on a 10 pt. scale, 5) able to provide informed consent, 6) has daily access to their own iPhone or Android smartphone, and 7) is a fluent English or Spanish speaker.

Disqualifiers

1) current participation in substance abuse treatment, 2) in psychotherapy for anxiety or depression, 3) concurrent use of medication for anxiety or depression, 4) active suicidality (ideation, intent, and/or plan), or 5) current psychosis.

Trial design

Design model

Single group

Treatments tested in this trial

Impacto (Mobile App)
Behavioral
This is the mobile app to be developed and evaluated in this project. It is designed for both English and Spanish languages and is culturally tailored for Hispanic/Latino/Latinx individuals who smoke. Impacto will be developed for both iOS and Android platforms. The mobile app aims to aid smoking cessation by targeting elevated anxiety sensitivity.

Treatment groups

56 Participants

are divided into 1 treatment group

Group A: ImpactoExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

7-Day Point Prevalence Smoking Abstinence

7-day point prevalence smoking status (verification via carbon monoxide).

Time frame

End of treatment (Week 8)

Secondary outcomes

Anxiety Sensitivity

Anxiety sensitivity will be assessed using the Short Scale Anxiety Sensitivity Index (SSASI).

Time frame

Baseline, week 4, and end of treatment (Week 8)

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Houston

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: